AT84066T
Electrolyte solutions and in vitro use thereof.
Abstract
This record has no abstract on file.
Term
Term ended
Expired 24 June 2005, 21.3 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
52 members in 12 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 62310284 | United States of America | A | |
| 8501203 | United States of America | W |
Members52
| Document | Office | Kind | |
|---|---|---|---|
| WO8600227A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO8600335A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4540285A | Australia | A | |
| AU4634685A | Australia | A | |
| EP0185759A1 | European Patent Office (EPO) | A1 | |
| EP0188529A1 | European Patent Office (EPO) | A1 | |
| JPS61502933A | Japan | A | |
| JPS61502943A | Japan | A | |
| EP0185759A4 | European Patent Office (EPO) | A4 | |
| IL81030A0 | Israel | A0 | |
| IL81030D0 | Israel | D0 | |
| US4663166A | United States of America | A | |
| US4663289A | United States of America | A | |
| WO8703808A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6776887A | Australia | A | |
| CN86108978A | China | A | |
| EP0249667A1 | European Patent Office (EPO) | A1 | |
| JPS63502274A | Japan | A | |
| EP0188529A4 | European Patent Office (EPO) | A4 | |
| CA1264442A | Canada | A | |
| AU4771690A | Australia | A | |
| CA1280082C | Canada | C | |
| AU6855890A | Australia | A | |
| US5100677A | United States of America | A | |
| CA1304688C | Canada | C | |
| EP0249667B1 | European Patent Office (EPO) | B1 | |
| AT80303T | Austria | T | |
| ATE80303T1 | Austria | T1 | |
| DE3686718D1 | Germany | D1 | |
| EP0185759B1 | European Patent Office (EPO) | B1 | |
| AT82500T | Austria | T | |
| ATE82500T1 | Austria | T1 | |
| DE3586844D1 | Germany | D1 | |
| EP0188529B1 | European Patent Office (EPO) | B1 | |
| AT84066TThis record | Austria | T | |
| ATE84066T1 | Austria | T1 | |
| DE3586946D1 | Germany | D1 | |
| DE3686718T2 | Germany | T2 | |
| GR3006492T3 | Greece | T3 | |
| DE3586844T2 | Germany | T2 | |
| AU6066994A | Australia | A | |
| ES2052495T3 | Spain | T3 | |
| AU7746694A | Australia | A | |
| AU2488097A | Australia | A | |
| US6020007A | United States of America | A | |
| US2003013765A1 | United States of America | A1 | |
| EP0185759B2 | European Patent Office (EPO) | B2 | |
| USRE38604E | United States of America | E | |
| EP0249667B2 | European Patent Office (EPO) | B2 | |
| US2005058724A1 | United States of America | A1 | |
| ES2052495T5 | Spain | T5 | |
| DE3686718T3 | Germany | T3 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 85903546
Titles2
- German
- ELEKTROLYTLOESUNGEN UND DEREN IN-VITRO-VERWENDUNG.
- English
- ELECTROLYTE SOLUTIONS AND ITS IN VITRO USE.
Classification
- CPC, 4
- C12N5/0018
- A61K33/10
- A61K33/14
- C12N2500/12
- IPC, 5
- A61K33 10
- A61K33 14
- C12N5 00
- C12N5 07
- C12N5 071